Targeted Integration Into The Albumin (Alb) Locus As A Treatment For Hereditary Methylmalonic Acidemia (MMA) Caused By Methylmalonyl-coA Mutase (MUT) Deficiency

Technology
E-034-2019
Patent ID
E-034-2019-0-US-07
Country
US
Application Type
National Stage
Patent Status
Pending
Patent Number
 
Publication Number
US-2022-0218843-A1
Application Number
17/267,482
IC
NHGRI
Date Filed
Date Issued
 
Patent PDF